- Trials with a EudraCT protocol (203)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (3)
203 result(s) found for: Fetus.
Displaying page 1 of 11.
EudraCT Number: 2017-000583-15 | Sponsor Protocol Number: 60858 | Start Date*: 2017-08-11 | |||||||||||
Sponsor Name:Leiden University Medical Center | |||||||||||||
Full Title: Randomized controlled trial on the use of EPO to reduce top-up transfusions in neonates with red blood cell alloimmunization treated with intrauterine transfusions | |||||||||||||
Medical condition: Hemolytic disease of the newborn due to red blood cell alloimmunization | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-003603-61 | Sponsor Protocol Number: 002 | Start Date*: 2017-07-19 | ||||||||||||||||
Sponsor Name: | ||||||||||||||||||
Full Title: Clinical trial on the administration of 3 doses of betamethasone (12 mg) in 18 hours apart in twin pregnancy patients with threatened preterm birth treated by Atosiban, rather than 2 doses of betam... | ||||||||||||||||||
Medical condition: Premature delivery in twin pregnancies | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: BE (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-010759-29 | Sponsor Protocol Number: 001 | Start Date*: 2009-04-27 | ||||||||||||||||
Sponsor Name:Cliniques Universitaires Saint-Luc | ||||||||||||||||||
Full Title: étude clinique sur l’administration de 3 doses de betaméthasone (12mg) à 18 heures d’intervalle lors d’une menace d’accouchement prématuré dans les grossesses gémellaires traitées par Atosiban, plu... | ||||||||||||||||||
Medical condition: Premature delivery in twin pregnancies | ||||||||||||||||||
|
||||||||||||||||||
Population Age: In utero, Under 18, Adults | Gender: Female | |||||||||||||||||
Trial protocol: BE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-011017-24 | Sponsor Protocol Number: ADNC-0726 | Start Date*: 2009-08-03 | ||||||||||||||||
Sponsor Name:LFB Biotechnologies | ||||||||||||||||||
Full Title: A Phase II, open-label, randomised, dose-finding study to compare the efficacy (in terms of clearance of RhD-positive RBCs) and safety of LFB-R593, a monoclonal anti-RhD antibody, vs Rhophylac®, a ... | ||||||||||||||||||
Medical condition: Prophyllaxis against RhD isoimmunisation during pregnancy (anti-D prophylaxis) Treatment of RhD negative individuals after incompatible transfusions with blood components containing RhD-positive r... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2017-004958-42 | Sponsor Protocol Number: MOM-M281-003 | Start Date*: 2019-01-11 | |||||||||||
Sponsor Name:Momenta Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Multicenter, Open-Label Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Pregnant Women at High Risk for Early Onset Severe Hemolytic Disease ... | |||||||||||||
Medical condition: Early onset Severe Hemolytic Disease of the fetus and newborn (HDFN) | |||||||||||||
|
|||||||||||||
Population Age: In utero, Under 18, Adults | Gender: Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) BE (Ongoing) NL (Ongoing) SE (Completed) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-007344-34 | Sponsor Protocol Number: 01-11-2008 | Start Date*: 2009-08-03 | ||||||||||||||||
Sponsor Name:Academic Medical Centre | ||||||||||||||||||
Full Title: External Cephalic Version with uterine relaxation: atosiban versus fenoterol, a multi-centre trial | ||||||||||||||||||
Medical condition: ECV of the fetus in breech position is a safe and relatively simple obstetrical intervention that reduces the incidence of caesarean section for breech position at term. Tocolysis can enhance the s... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-005784-33 | Sponsor Protocol Number: 540000031 | Start Date*: 2009-01-21 | ||||||||||||||||
Sponsor Name:Maternté Régionale Universitaire de Nancy | ||||||||||||||||||
Full Title: Effet du néfopam sur la montée laiteuse après césarienne ( étude randomisée en double insu) | ||||||||||||||||||
Medical condition: Deux groupes de parturientes devant bénéficier d’une césarienne sont tirés au sort pour recevoir soit de l’Acupan*, soit du Perfalgan*, pour compléter l’analgésie post-opératoire assurée par la mo... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: FR (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-004940-29 | Sponsor Protocol Number: SANNARU486 | Start Date*: 2005-01-13 | |||||||||||
Sponsor Name:AZIENDA SANITARIA OSPEDALIERA O.I.R.M. - S. ANNA | |||||||||||||
Full Title: VOLUNTARY TERMINATION OF PREGNANCY WITH MIFEPRISTONE RU486 AND MISOPROSTOL | |||||||||||||
Medical condition: VOLUNTARY TERMINATION OF PREGNANCY LAW N.194/1978 | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002924-35 | Sponsor Protocol Number: APHP180592 | Start Date*: 2021-01-18 |
Sponsor Name:ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS | ||
Full Title: Prenatal treatment of congenital cytomegalovirus infection with letermovir randomized against valaciclovir | ||
Medical condition: Step 1: Maternal administration of 1 tablet of Letermovir (240 mg or 480 mg /day) during 3 days before TOP Step 2: Maternal daily administration of 240 or 480 milligrams of letermovir (1x240 mg-ta... | ||
Disease: | ||
Population Age: Children, Under 18, Adults | Gender: Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-000467-23 | Sponsor Protocol Number: 1 | Start Date*: 2007-08-23 | ||||||||||||||||||||||||||
Sponsor Name:Erasmus MC | ||||||||||||||||||||||||||||
Full Title: Maternal and fetal haemodynamic response to Nifedipine tocolysis in normotensive pregnant women. | ||||||||||||||||||||||||||||
Medical condition: A more detailed investigation of the haemodynamic effect on the mother and fetus of Nifedipine tocolysis . Tocolysis will be used to facilitate external cephalic version for breech presentation at ... | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: In utero, Under 18, Adults | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-001842-33 | Sponsor Protocol Number: 100-2013 | Start Date*: 2013-08-19 | |||||||||||
Sponsor Name:OYS | |||||||||||||
Full Title: The Preterm infants’ Paracetamol Study -- PreParaS | |||||||||||||
Medical condition: premature infant | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Restarted) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-000470-19 | Sponsor Protocol Number: CHUB-PD001 | Start Date*: 2014-04-17 |
Sponsor Name:Centre Hospitalier Universitaire Brugmann | ||
Full Title: comparative study between conventional epidural versus ambulatory epidural: effect during labor in pregnant women | ||
Medical condition: a single fetus pregnancy over 36 weeks and less than 42 weeks in adult nulliparous | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-001368-35 | Sponsor Protocol Number: 31520 | Start Date*: 2008-04-24 | |||||||||||
Sponsor Name:Oulu University Hospital | |||||||||||||
Full Title: Efficacy and Safety of Targeting Lower Arterial Oxygen Saturations to Reduce Oxygen Toxicity and Oxidative Stress in Very Preterm Infants | |||||||||||||
Medical condition: Study population: Children born extremely preterm (before 28 weeks of gestation). Primary outcome: 1) Death before a corrected age of 18 months and survival with severe disability. 2) The growth ... | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002256-25 | Sponsor Protocol Number: HYPATIA | Start Date*: 2018-03-09 | |||||||||||
Sponsor Name:Guy's and St Thomas' NHS Foundation Trust | |||||||||||||
Full Title: HYPATIA: A prospective randomised controlled trial of HYdroxychloroquine to improve Pregnancy outcome in women with AnTIphospholipid Antibodies | |||||||||||||
Medical condition: Pregnant women with antiphospholipid antibodies | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-002548-26 | Sponsor Protocol Number: 0139 | Start Date*: 2020-12-16 | ||||||||||||||||
Sponsor Name:Royal College of Surgeons in Irlenad | ||||||||||||||||||
Full Title: Can Pentoxifylline improve long-term outcomes in preterm infants with late-onset sepsis or necrotizing enterocolitis? A pragmatic, randomised, placebo controlled trial | ||||||||||||||||||
Medical condition: Late onset sepsis & necrotising enterocolitis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: IE (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003699-60 | Sponsor Protocol Number: KIBB01 | Start Date*: 2018-09-28 |
Sponsor Name:Karolinska Institutet | ||
Full Title: An exploratory, open label, multiple dose, multicentre phase I/II trial evaluating safety and efficacy of postnatal or prenatal and postnatal intravenous administration of allogeneic expanded fetal... | ||
Medical condition: Treatment of Osteogenesis Imperfecta (OI) type III and severe type IV. | ||
Disease: | ||
Population Age: In utero, Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: SE (Temporarily Halted) | ||
Trial results: (No results available) |
EudraCT Number: 2011-003952-37 | Sponsor Protocol Number: REMIVER | Start Date*: 2012-04-24 |
Sponsor Name:LUIS FERNÁNDEZ- LLEBREZ DEL REY | ||
Full Title: Open randomized controlled trial to evaluate the efficacy and safety of remifentanil versus nitrous oxide in the external cephalic version at term in singleton pregnancy in breech presentation, COD... | ||
Medical condition: The objective is to demonstrate the superiority of remifentanil versus nitrous oxide as adjuvant analgesic treatment to increase the chances of success of external cephalic version in the managemen... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-001654-15 | Sponsor Protocol Number: NL53018.015.15 | Start Date*: 2015-10-15 |
Sponsor Name:Máxima Medisch Centrum | ||
Full Title: Intrauterine resuscitation during term labor by maternal hyperoxygenation. | ||
Medical condition: Fetal distress during the second stage of labor. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-010381-30 | Sponsor Protocol Number: 2.4 | Start Date*: 2009-03-19 | |||||||||||
Sponsor Name:Isala klinieken | |||||||||||||
Full Title: Aerosolised salbutamol in two doses as a treatment for preterm infants with developing bronchopulmonary dysplasia. | |||||||||||||
Medical condition: Preterm infants developing bronchopulmonary dysplasia | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-005198-30 | Sponsor Protocol Number: BBHV.02-2012 | Start Date*: 2013-04-30 |
Sponsor Name:LAURA TARRATS VELASCO | ||
Full Title: EFFICACY OF ADMINISTRATION OF HYOSCINE BUTILBROMIDE (BUSCOPAN®) ON PREGNANT WOMEN IN FIRST STAGE OF LABOUR IN CASE OF CERVIX RIGIDITY. (BBH V.04-2013 EUDRACT: 2012-005198-30) | ||
Medical condition: in case of cervix rigidity determination in first stage of labour, pregnant women will be offered to participate and if they accept they´ll be randomised to test or control group. Placebo or treat... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.